title: In vitro superiority of dual-chambered peritoneal dialysis solution with possible clinical benefits.
authors.affiliation: Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany. Jutta.Passlick-Deetjen@fmc-ag.de
authors.forename: J
authors.initials: J
authors.lastname: Passlick-Deetjen
authors.forename: M
authors.initials: M
authors.lastname: Pischetsrieder
authors.forename: J
authors.initials: J
authors.lastname: Witowski
authors.forename: T O
authors.initials: TO
authors.lastname: Bender
authors.forename: A
authors.initials: A
authors.lastname: Jörres
authors.forename: C
authors.initials: C
authors.lastname: Lage
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D015314:Dialysis Solutions / Q000008:administration & dosage / Q000009:adverse effects; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000295:instrumentation*; D010537:Peritoneum / Q000378:metabolism; D013242:Sterilization
chemical_list: D015314:Dialysis Solutions; D017127:Glycation End Products, Advanced; D005947:Glucose